共 50 条
- [33] VARIABILITY OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATIONS IN SERUM DURING ERLOTINIB THERAPY AND ITS CLINICAL IMPLICATIONS: EXPLORATORY ANALYSIS OF A PHASE II STUDY OF ERLOTINIB IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) HARBORING EGFR MUTATIONS [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S384 - S385
- [34] Epidermal growth factor receptor polymorphisms and clinical outcomes in non-small-cell lung cancer patients treated with gefitinib [J]. PHARMACOGENOMICS JOURNAL, 2008, 8 (02): : 129 - 138
- [35] Epidermal growth factor receptor polymorphisms and clinical outcomes in non-small-cell lung cancer patients treated with gefitinib [J]. The Pharmacogenomics Journal, 2008, 8 : 129 - 138